Viking Therapeutics Inc (NASDAQ:VKTX) has a beta value of 0.83 and has seen 1.08 million shares traded in the recent trading session. The company, currently valued at $2.72B, closed the recent trade at $24.20 per share which meant it gained $0.05 on the day or 0.23% during that session. The VKTX stock price is -238.84% off its 52-week high price of $82.00 and 3.84% above the 52-week low of $23.27. If we look at the company’s 10-day average daily trading volume, we find that it stood at 3.01 million shares traded. The 3-month trading volume is 4.37 million shares.
The consensus among analysts is that Viking Therapeutics Inc (VKTX) is Buy stock at the moment, with a recommendation rating of 1.12. 0 analysts rate the stock as a Sell, while 1 rate it as Overweight. 0 out of 7 have rated it as a Hold, with 6 advising it as a Buy. 0 have rated the stock as Underweight. The expected earnings per share for the stock is -0.32.
Viking Therapeutics Inc (NASDAQ:VKTX) trade information
Sporting 0.23% in the green today, the stock has traded in the red over the last five days, with the highest price hit on recent trading when the VKTX stock price touched $24.20 or saw a rise of 14.15%. Year-to-date, Viking Therapeutics Inc shares have moved -39.85%, while the 5-day performance has seen it change -13.49%. Over the past 30 days, the shares of Viking Therapeutics Inc (NASDAQ:VKTX) have changed -5.82%. Short interest in the company has seen 24.21 million shares shorted with days to cover at 4.34.
Wall Street analysts have a consensus price target for the stock at $110, which means that the shares’ value could jump 78.0% from the levels at last check today. The projected low price target is $74.0 while the price target rests at a high of $110.0. In that case, then, we find that the latest price level in today’s session is -354.55% off the targeted high while a plunge would see the stock gain -205.79% from the levels at last check today.
Viking Therapeutics Inc (VKTX) estimates and forecasts
The company’s shares have lost -60.73% over the past 6 months. Revenue growth from the last financial year stood is estimated to be 0.00%. If we evaluate the company’s growth over the last 5-year and for the next 5-year period, we find that annual earnings growth was -23.00% over the past 5 years.
VKTX Dividends
Viking Therapeutics Inc is expected to release its next earnings report on 2025-Feb-04 this year, and investors are excited at the prospect of better dividends despite the company’s debt issue.
Viking Therapeutics Inc (NASDAQ:VKTX)’s Major holders
Insiders own 2.70% of the company shares, while shares held by institutions stand at 74.24% with a share float percentage of 76.30%. Investors are also buoyed by the number of investors in a company, with Viking Therapeutics Inc having a total of 540.0 institutions that hold shares in the company. The top two institutional holders are FMR LLC with over 16.54 million shares worth more than $876.8 million. As of 2024-06-30, FMR LLC held 14.9835% of shares outstanding.
The other major institutional holder is VANGUARD GROUP INC, with the holding of over 10.1 million shares as of 2024-06-30. The firm’s total holdings are worth over $535.26 million and represent 9.7599% of shares outstanding.
Also the top two Mutual Funds that are holding company’s shares are Fidelity Mt. Vernon Street Trust-Fidelity Growth Company Fund and VANGUARD INDEX FUNDS-Vanguard Total Stock Market Index Fund. As of Jan 31, 2025, the former fund manager holds about 3.36% shares in the company for having 3.77 shares of worth $92.13 million while later fund manager owns 3.3 shares of worth $80.65 million as of Dec 31, 2024, which makes it owner of about 2.94% of company’s outstanding stock.
